Several pathways have been postulated to underlie these functions of fibulin-3: A mechanism first observed in pancreatic cancer cells and later shown in other solid tumors involves activation of receptor tyrosine kinases (such as the EGF receptor), resulting in MAPK and Akt signaling (19, 24). Here, EFEMP1 is linked to pancreatic neoplasm.